<DOC>
	<DOCNO>NCT02096744</DOCNO>
	<brief_summary>To establish bioequivalence adhesion property transdermal clonidine prepare OppanolÂ® brand polyisobutylene ( PIB ) vs. transdermal clonidine prepare VistanexTM brand polyisobutylene ( PIB ) healthy male female volunteer .</brief_summary>
	<brief_title>Bioequivalence Two Transdermal Clonidine Administrations Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Clonidine</mesh_term>
	<criteria>Inclusion criterion : 1 . A complete medical history , include physical examination , vital sign ( BP , PR ) , 12lead ECG , clinical laboratory test 2 . Age great equal 18 Age less equal 65 year 3 . BMI great equal 18.5 BMI less equal 32.0 kg/m2 ( Body Mass Index ) 4 . Signed date write informed consent prior admission study 5 . Male subject , female meet follow criterion least 30 day first study drug administration 30 day trial completion : Using adequate contraception , e.g . follow method plus condom : implant , injectables , combine oral contraceptive , intrauterine device ( IUD ) Sexually abstinent Have vasectomise sexual partner ( vasectomy least one year prior enrolment ) Surgically sterilise ( include hysterectomy ) Postmenopausal define least one year spontaneous amenorrhea Exclusion criterion : 1 . Any finding medical examination ( include BP , PR ECG ) deviate normal 2 . Repeated measurement supine systolic blood pressure outside range 100140 mm Hg diastolic blood pressure outside range 6090 mm Hg pulse less 55 bpm 3 . Any subject orthostatic hypotension baseline screen exam 4 . Any laboratory value outside reference range 5 . Any evidence clinically relevant concomitant disease 6 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic ( include insulindependent diabetes ) , immunological hormonal disorder 7 . Diseases central nervous system ( epilepsy ) psychiatric disorder ( depression ) neurological disorder ( neuropathy ) 8 . History relevant orthostatic hypotension , faint spell blackouts 9 . Chronic relevant acute infection 10 . History relevant allergy/hypersensitivity 11 . Intake drug long halflife ( great 24 hour ) within least one month le 10 halflives respective drug prior administration trial . 12 . Use drug might reasonably influence result trial within 10 day prior administration trial 13 . Participation another trial investigational drug within two month prior administration trial 14 . Any concomitant therapy 15 . Smoker 16 . History alcohol abuse 17 . History drug abuse 18 . Blood donation 19 . Excessive physical activity ( within one week prior administration trial ) 20 . Subjects swim treatment period trial 21 . Any condition skin , include eczema , psoriasis , lymphedema , involve upper arm area would utilize application treatment 22 . Pregnancy plan become pregnant within two month study completion 23 . Positive pregnancy test 24 . A screening ECG display firstdegree atrioventricular block ( PR interval &gt; 0.20 second ) conduction disturbance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>